Quince Therapeutics Inc’s filing revealed that its CEO AND CHIEF MEDICAL OFFICER Thye Dirk acquired Company’s shares for reported $53900.0 on Aug 30 ’24. In the deal valued at $0.70 per share,77,000 shares were bought. As a result of this transaction, Thye Dirk now holds 843,941 shares worth roughly $1.5 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Thye Dirk bought 77,500 shares, generating $53,475 in total proceeds. Upon buying the shares at $0.69, the CEO AND CHIEF MEDICAL OFFICER now owns 766,941 shares.
Before that, Ryan Charles S. bought 48,387 shares. Quince Therapeutics Inc shares valued at $31,452 were divested by the PRESIDENT at a price of $0.65 per share. As a result of the transaction, Ryan Charles S. now holds 122,461 shares, worth roughly $0.22 million.
Price Performance Review of QNCX
On Friday, Quince Therapeutics Inc [NASDAQ:QNCX] saw its stock fall -6.32% to $1.78. Over the last five days, the stock has gained 4.71%. Quince Therapeutics Inc shares have risen nearly 69.52% since the year began. Nevertheless, the stocks have risen 100.00% over the past one year. While a 52-week high of $1.95 was reached on 11/15/24, a 52-week low of $0.51 was recorded on 08/15/24. SMA at 50 days reached $1.0101, while 200 days put it at $0.9463.
Levels Of Support And Resistance For QNCX Stock
The 24-hour chart illustrates a support level at 1.5555, which if violated will result in even more drops to 1.3309. On the upside, there is a resistance level at 2.0701. A further resistance level may holdings at 2.3601. The Relative Strength Index (RSI) on the 14-day chart is 67.44, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.1931, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 32.46%. Stochastics %K at 79.34% indicates the stock is a holding.
How much short interest is there in Quince Therapeutics Inc?
A steep rise in short interest was recorded in Quince Therapeutics Inc stocks on 2024-10-31, growing by 0.43 million shares to a total of 2.35 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 1.92 million shares. There was a rise of 18.12%, which implies that there is a positive sentiment for the stock.
